Nucleic acid amplification-based HER2I655V molecular detection for breast cancer

Single Nucleotide Polymorphism at codon 655 of HER2 gene has been extensively evaluated for its role as a susceptible biomarker for breast cancer development and the contradictive result of its role has been a debate among researchers as evidenced from case-control studies. Three platforms of molecu...

Full description

Bibliographic Details
Main Authors: Bugi Ratno Budiarto, Pimpin Utama Pohan, Desriani
Format: Article
Language:English
Published: Turkiye Klinikleri 2019-04-01
Series:Journal of Oncological Sciences
Online Access:http://www.sciencedirect.com/science/article/pii/S2452336418300475
_version_ 1797917357569474560
author Bugi Ratno Budiarto
Pimpin Utama Pohan
Desriani
author_facet Bugi Ratno Budiarto
Pimpin Utama Pohan
Desriani
author_sort Bugi Ratno Budiarto
collection DOAJ
description Single Nucleotide Polymorphism at codon 655 of HER2 gene has been extensively evaluated for its role as a susceptible biomarker for breast cancer development and the contradictive result of its role has been a debate among researchers as evidenced from case-control studies. Three platforms of molecular detection systems named PCR-RFLP, TaqMan assay, and AS-PCR have been used intensively in elucidating this important SNP with considering the affordability and simplicity of detection especially in research format which employs plenty of samples such as in the epidemiological study. Nevertheless, methodological related-bias generated from the association study between HER2I655V SNP and breast cancer risk becomes primary drawback that must be addressed seriously in an attempt to obtain a solid conclusion. This review will discuss the application of nucleic acid amplification-based methods for HER2I655V SNP detection, the potency of bias generated by these genotyping technologies, and strategies to improve their reliability of detection. Keywords: SNP, HER2I655V gene, Breast cancer, Genotyping methods, Genotyping errors
first_indexed 2024-04-10T13:12:02Z
format Article
id doaj.art-ef995670720349088b81bf0cc04efe09
institution Directory Open Access Journal
issn 2452-3364
language English
last_indexed 2024-04-10T13:12:02Z
publishDate 2019-04-01
publisher Turkiye Klinikleri
record_format Article
series Journal of Oncological Sciences
spelling doaj.art-ef995670720349088b81bf0cc04efe092023-02-15T16:12:37ZengTurkiye KlinikleriJournal of Oncological Sciences2452-33642019-04-01513141Nucleic acid amplification-based HER2I655V molecular detection for breast cancerBugi Ratno Budiarto0Pimpin Utama Pohan1 Desriani2Research Center for Biotechnology, Indonesian Institute of Sciences (LIPI), Jalan Raya Bogor Km. 46, Cibinong, 16911, Indonesia; Corresponding author. Research Center for Biotechnology, Indonesian Institute of Sciences-LIPI, Jalan Raya Bogor Km. 46, Cibinong, 16911, Bogor, Jawa Barat, Indonesia. Tel.: +62 021 8754587; fax: +62 021 8754588.Faculty of Medicine, University of North Sumatra, Jalan Dr. T. Mansyur No.5, Padang Bulan, Medan Baru, Kota Medan, Sumatera Utara, IndonesiaResearch Center for Biotechnology, Indonesian Institute of Sciences (LIPI), Jalan Raya Bogor Km. 46, Cibinong, 16911, IndonesiaSingle Nucleotide Polymorphism at codon 655 of HER2 gene has been extensively evaluated for its role as a susceptible biomarker for breast cancer development and the contradictive result of its role has been a debate among researchers as evidenced from case-control studies. Three platforms of molecular detection systems named PCR-RFLP, TaqMan assay, and AS-PCR have been used intensively in elucidating this important SNP with considering the affordability and simplicity of detection especially in research format which employs plenty of samples such as in the epidemiological study. Nevertheless, methodological related-bias generated from the association study between HER2I655V SNP and breast cancer risk becomes primary drawback that must be addressed seriously in an attempt to obtain a solid conclusion. This review will discuss the application of nucleic acid amplification-based methods for HER2I655V SNP detection, the potency of bias generated by these genotyping technologies, and strategies to improve their reliability of detection. Keywords: SNP, HER2I655V gene, Breast cancer, Genotyping methods, Genotyping errorshttp://www.sciencedirect.com/science/article/pii/S2452336418300475
spellingShingle Bugi Ratno Budiarto
Pimpin Utama Pohan
Desriani
Nucleic acid amplification-based HER2I655V molecular detection for breast cancer
Journal of Oncological Sciences
title Nucleic acid amplification-based HER2I655V molecular detection for breast cancer
title_full Nucleic acid amplification-based HER2I655V molecular detection for breast cancer
title_fullStr Nucleic acid amplification-based HER2I655V molecular detection for breast cancer
title_full_unstemmed Nucleic acid amplification-based HER2I655V molecular detection for breast cancer
title_short Nucleic acid amplification-based HER2I655V molecular detection for breast cancer
title_sort nucleic acid amplification based her2i655v molecular detection for breast cancer
url http://www.sciencedirect.com/science/article/pii/S2452336418300475
work_keys_str_mv AT bugiratnobudiarto nucleicacidamplificationbasedher2i655vmoleculardetectionforbreastcancer
AT pimpinutamapohan nucleicacidamplificationbasedher2i655vmoleculardetectionforbreastcancer
AT desriani nucleicacidamplificationbasedher2i655vmoleculardetectionforbreastcancer